Skip to content

Surgical treatment of BCG induced suppurative lymphadenitis

Comparison of surgical techniques in the treatment of suppurative lymphadenitis caused by BCG vaccination

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015011420663N1
Enrollment
39
Registered
2015-04-29
Start date
2013-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BCG induced suppurative LYMPHADENITIS. [Need for immunization against tuberculosis [BCG

Interventions

Intervention 1: In the first group lymphadenitis caused by BCG vaccination can be treated by using needle aspiration, So that lymph node will be aspirated with needle number 21. Intervention 2: In the
Treatment - Surgery
In the first group lymphadenitis caused by BCG vaccination can be treated by using needle aspiration, So that lymph node will be aspirated with needle number 21
In the second group in the first group lymphadenitis caused by BCG vaccination can be treated by using incision & drainage, So that lymph node will be incised on the maximum point of fluctuation. Site
In the third group lymph node will totally excised, first, the patient is underwent general anesthesia, then we will incise the skin and disconnect lymph nodes supportive tissues. Finally lymph nodes

Sponsors

Tabriz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 6 Months

Inclusion criteria

Inclusion criteria: Inclusion criteria: The risk of BCG lymphadenitis Exclusion criteria: The development of any systemic diseases such as malignant lymphadenopathy is the author of it ; patients with a history of tuberculous meningitis or tuberculosis milliary

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recovery from BCG lymphadenitis with 3 different surgical techniques. Timepoint: 2 and 6 month after vaccine injection. Method of measurement: Clinical examination of recurrence.

Secondary

MeasureTime frame
Reviewing the formation of keloids, scars, skin indentations, deformity, edema. Timepoint: after six month. Method of measurement: clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hosein Shiri

Tabriz University of Medical Science

hosein_shiri@yahoo.com+98 41 3334 1317

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026